Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

High Dose Interval Vitamin D Supplementation in Patients With IBD Receiving Remicade

NCT03162432 is registered in ClinicalTrials.gov with Boston Children's Hospital as lead sponsor.

NCT NCT03162432
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03162432 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
High Dose Interval Vitamin D Supplementation in Patients With IBD Receiving Remicade
Lead sponsor
Boston Children's Hospital
Phase
Phase 3
Overall status
Unknown status
Start date
August 1, 2017
Completion date
December 1, 2023
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

crohn disease, ibd, ulcerative colitis